Abivax S.A.
ABVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001956827
No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 303 institutions reported holding it in 13F filings for Q2 2026, worth $7.18B in total; Maverick Capital is the only superinvestor holding it.
Other share classesAAVXF
13F holders, Q4 2024
Institutional positions in Abivax S.A. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +8 vs. Q3 2024
- Shares held
- 29.9M
- +2.48M (+9.0%) vs. Q3 2024
- Total value
- $218.6M
- −$94.3M (−30.1%) vs. Q3 2024
- New holders
- 14
- 14 more added
- Sold out
- 6
- 9 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 303 | $7.18B |
| Q1 2026 | 254 | $5.53B |
| Q4 2025 | 247 | $7.61B |
| Q3 2025 | 165 | $4.41B |
| Q2 2025 | 43 | $234.6M |
| Q1 2025 | 46 | $198.5M |
| Q4 2024 | 48 | $218.6M |
| Q3 2024 | 40 | $312.8M |
| Q2 2024 | 38 | $371.6M |
| Q1 2024 | 36 | $334.2M |
| Q4 2023 | 30 | $227.8M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Abivax S.A.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 37 | $0 | 0.00% | +37 | New |
| Principal Securities, Inc. | 10 | $73 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 25 | $183 | 0.00% | −7−21.9% | Reduced |
| Financial Management Professionals, Inc. | 100 | $732 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 706 | $5.17K | 0.00% | +22+3.2% | Added |
| Barclays PLC | 1,095 | $8.02K | 0.00% | +1,095 | New |
| GAMMA Investing LLC | 3,976 | $29.1K | 0.00% | +3,976 | New |
| R Squared Ltd | 4,950 | $36.2K | 0.04% | +4,950 | New |
| Bank of America Corp | 5,536 | $40.5K | 0.00% | +1,990+56.1% | Added |
| Cubist Systematic Strategies, LLC | 7,557 | $55.3K | 0.00% | −8,896−54.1% | Reduced |
| HighTower Advisors, LLC | 10,000 | $73.2K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 11,668 | $85.4K | 0.00% | +11,668 | New |
| Guggenheim Capital LLC | 12,512 | $91.6K | 0.00% | +12,512 | New |
| Stonepine Capital Management, LLC | 15,000 | $109.8K | 0.09% | +15,000 | New |
| Geode Capital Management, LLC | 16,749 | $122.6K | 0.00% | +1,177+7.6% | Added |
| BNP Paribas Arbitrage, SA | 19,244 | $140.9K | 0.00% | +6,200+47.5% | Added |
| Two Sigma Investments, LP | 19,736 | $144.5K | 0.00% | +19,736 | New |
| Woodline Partners LP | 48,136 | $352.4K | 0.00% | −33,594−41.1% | Reduced |
| HighVista Strategies LLC | 49,064 | $359.1K | 0.13% | 00.0% | Unchanged |
| Shay Capital LLC | 50,029 | $366.2K | 0.09% | +50,029 | New |
| Point72 Asset Management, L.P. | 91,300 | $668.3K | 0.00% | −451,600−83.2% | Reduced |
| Atika Capital Management LLC | 103,929 | $760.8K | 0.10% | −9,702−8.5% | Reduced |
| Soleus Capital Management, L.P. | 125,000 | $915.0K | 0.07% | 00.0% | Unchanged |
| UBS Group AG | 174,873 | $1.28M | 0.00% | +174,182+25,207.2% | Added |
| Springhill Fund Asset Management (HK) Co Ltd | 207,600 | $1.52M | 2.47% | +207,600 | New |
| Kennedy Capital Management, Inc. | 225,470 | $1.65M | 0.04% | +1,656+0.7% | Added |
| Silverarc Capital Management, LLC | 285,120 | $2.09M | 0.47% | −176,540−38.2% | Reduced |
| Walleye Capital LLC | 302,642 | $2.22M | 0.02% | +45,225+17.6% | Added |
| Boothbay Fund Management, LLC | 406,903 | $2.98M | 0.09% | +406,903 | New |
| Standard Life Aberdeen plc | 424,181 | $3.11M | 0.01% | +107,750+34.1% | Added |
| Morgan Stanley | 479,326 | $3.51M | 0.00% | −25,426−5.0% | Reduced |
| Allostery Investments LP | 591,253 | $4.33M | 8.50% | +591,253 | New |
| Saturn V Capital Management LLC | 653,071 | $4.78M | 1.87% | +5,052+0.8% | Added |
| JPMorgan Chase & Co | 728,919 | $5.34M | 0.00% | +728,919 | New |
| Caligan Partners LP | 752,167 | $5.51M | 1.39% | +752,167 | New |
| Samsara BioCapital, LLC | 850,000 | $6.22M | 0.85% | 00.0% | Unchanged |
| Citadel Advisors LLC | 855,676 | $6.26M | 0.01% | +389,247+83.5% | Added |
| Millennium Management LLC | 931,179 | $6.82M | 0.01% | +285,542+44.2% | Added |
| Blackstone Group Inc. | 936,607 | $6.86M | 0.03% | −585,827−38.5% | Reduced |
| Commodore Capital LP | 1,284,110 | $9.40M | 0.69% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,345,780 | $9.85M | 0.68% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,436,047 | $10.5M | 0.74% | +450,413+45.7% | Added |
| Franklin Resources Inc | 1,466,062 | $10.7M | 0.00% | +141,710+10.7% | Added |
| ADAR1 Capital Management, LLC | 1,513,393 | $11.1M | 2.28% | +991,781+190.1% | Added |
| Great Point Partners LLC | 1,648,523 | $12.1M | 5.69% | −480,250−22.6% | Reduced |
| Cormorant Asset Management, LP | 2,130,000 | $15.6M | 0.86% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,579,209 | $26.2M | 0.98% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 6,056,596 | $44.3M | 4.33% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −530,861−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −410,710−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −139,983−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −34,939−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −30,910−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −11,365−100.0% | Sold out |